Revealing that they are working to secure additional sourcing of vaccines in the form of dose-sharing from higher-income countries, the facility said in a statement that they have so far made supplies to100 countries, 42 days after they supplied their very first batches to Ghana in late February.
So far, the Serum Institute has an agreement to supply 166 million doses to the Indian government, with another firm, Bharat Biotech, supplying 10 million doses. India also has licensing deals with the Russian Gamaleya Research Institute to produce 200 million doses of the Sputnik vaccine.
Dr. Yonas Tegnen Woldermariam the World Health Organization (WHO) Uganda Representative said though the European Medicines Agency (EMA) has just recommended that blood clots and low blood platelet count be listed among the Jab’s possible side effects, they have found the same effects more common in people who suffer severe COVID-19.
The spraying exercise is part of a five-year USAID-funded project in several districts of Eastern Uganda. It will involve the use of Fludora-Fusion, a new vector control solution that was recently prequalified by the World Health Organisation, after being tested against more than a dozen of resistant mosquito strains in Sub-Saharan Africa. The exercise will last 24 days, effective April 26.
The recommendation was made after a review of 63 cases of reported blood clots that developed moments after receiving the vaccine from several European countries. The majority of the cases were among females below 60 years of age, some aged 24, who developed clots after receiving their first vaccine jab.